Track topics on Twitter Track topics that are important to you
DURHAM, NC -- (Marketwired) -- 07/27/16 -- Tergus Pharma, (www.terguspharma.com), the industry leader in topical development, formulation, analysis, testing and clinical supply manufacturing has hired Graham Mott as Director of Business Development. Mott will lead sales and marketing efforts for the company.
Tergus is the industry leader in topical pharmaceutical formulation, development, skin biology & IVRT testing and Phase I - III cGMP clinical supply manufacturing. Mr. Mott has a strong track record of success and experience in the dermatological market.
"Hiring Graham Mott to lead business development and marketing will assist Tergus to continue our strong track record of growth," said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. "His expertise and track record are stellar and we are happy he has joined the company."
Mr. Mott earned his bachelor's degree from the University of Miami and an MBA in marketing and finance from the University of Phoenix. He has experience leading sales teams and bringing in strong results
Tergus has enjoyed strong growth for the past few years and has attracted top talent in topical formulation, development, testing, analysis and manufacturing. It continues to grow its footprint, recently expanding to a more than 28,000 square-foot facility that includes top-of-the-line R&D labs, cGMP manufacturing suite and the largest capability in the industry for IVRT and skin permeation studies. Tergus pioneered QbD for topical pharmaceuticals and continues to innovate and develop strategies that result in greater success for its clients.
Tergus offers complete topical pharmaceutical consulting services, development, formulation, analytical R&D, In Vitro Release Testing (IVRT), skin biology and cGMP clinical supplies manufacturing. The company has capability to produce clinical supplies up to 150kg using their state of the art manufacturing equipment. The company's motto is "Think Topical, Think Tergus."
Tergus (www.terguspharma.com) is the market leader in full-service topical pharmaceutical research, development, testing, analysis and manufacturing. The company has more than 20 years in business located in a state-of-the-art laboratory facility in Durham, North Carolina. The company has a long and stellar reputation for delivering quality and results for clients from formulation through manufacturing. Tergus pioneered Quality by Design (QbD) protocols for semi-solid delivery forms and has the largest bank of In Vitro Release Testing (IVRT) Franz Diffusion cells. The company's motto is "Think Topical. Think Tergus."
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=3038248Contact: Tinka Bowes Tergus Pharma (919) 549-9700 NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...